Author: Physician's Weekly Admin

Participating in CHHiP and its radiotherapy quality assurance program helped many centers to...

The National Oncology Trainees Collaborative For Healthcare Research is a research organization...

Since the disclosure of cancer-causing genetic biomarkers, many of these biomarkers like...

Cellular breakdown in the lungs is the most noteworthy disease which causes the maximum amount of...

During the coronavirus pandemic disease of 2019, many clinics and hospitals were necessitated to...

There are approximately 367,000 new cancer cases reported in the UK every year. The common types...

There are a lot of biological benefits of using flash radiotherapy which involves ultra high dose...

Generally most of the cases of locally advanced ineradicable thoracic oesophageal squamous cell...

The CHHiP (Conventional or Hypofractionated High-dose Intensity Modulated Radiotherapy In Prostate...

An analysis of 4 SBRT of low and intermediate risk prostate cancer was conducted for the...

The sudden outbreak of the deadly coronavirus has put the country of the United Kingdom in the...

Adjuvant trastuzumab for patients with HER2-positive early breast cancer showed significant...

The administration of trastuzumab in Canada has increased significantly. Patients’ median...

Clinical trials often collect and assess survival (or time to an event) data from patients. The...

This editorial aims to simplify the understanding of percentage depth doses for photons and...

The LORIS trial is an ongoing clinical trial on low-risk ductal carcinoma in situ (DCIS). DCIS...

Skin toxicity is the most common side-effect of radiotherapy for breast cancer. This study aimed...

The cases of anal squamous cell cancer (SCCA) are increasing over time. Even though...

Radiotherapy or chemoradiation of squamous cell carcinoma of the head and neck produces high...